RSS

Flynn Pharma

The UK’s Competition and Markets Authority (CMA) dishes the two firms a record fine of nearly £90 million for charging excessive prices to the NHS for an anti-epilepsy drug. more

News

Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. more

News